Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Artificial Eye Market Analysis, Increasing prevalence of Ophthalmic Diseases to boost market growth, CAGR 8.16% by 2026 - Technavio


NEW YORK, Sept. 25, 2022 /PRNewswire/ -- The artificial eye market is expected to grow by USD 34140.17 thousand at a CAGR of 8.16% during the forecast period of 2021-2026. Technavio report is compiled on research from a mix of primary interviews and secondary research, along with analytical tools that have been used to build the forecast and predictive models.

The report will comprise of detailed analysis of emerging market trends, regional outlook, competitive landscape, and comprehensive analysis of different market segments helping you to plan your business strategies. Grab your Free Sample Report on the Artificial Eye Market Right Away!

The artificial eye market provides a detailed analysis of the market overview, market drivers, opportunities, and potential applications.

Artificial Eye Market Vendors

Find additional highlights on the growth strategies adopted by vendors and their product
offerings, Download Free Sample Report.

Parent Market Analysis

Technavio categorizes the global artificial eye market as a part of the global healthcare equipment market within the global healthcare market. External factors influencing the parent market's growth potential in the coming years have been thoroughly investigated in our research analysis, to know more about the levels of growth of the Artificial Eye Market throughout the forecast period.

Artificial Eye Market Value Chain Analysis

The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the Artificial Eye Market includes the following core components:

The artificial eye market will be affected by increasing demand for custom-made ocular prostheses. Apart from this, other market trends include a paradigm shift of ocular prosthesis procedures from hospitals to ambulatory surgery centers (ASCs), Increasing medical tourism for low-cost ocular prosthesis treatments.

The market analysis is done on the basis of regional distribution helping us to utilize & make performance estimations for the international market over the period from 2021-2026. The artificial eye market research report shed light on the foremost regions: North America, Europe, Asia, and Rest of the World (ROW). Buy Sample Report.

Related Reports:
Medical Device Contract Manufacturing Market by Device and Geography - Forecast and Analysis 2022-2026: The medical device contract manufacturing market share is expected to increase by USD 46.18 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 11.19%.

Proton Therapy Market by Product and Geography - Forecast and Analysis 2022-2026: The proton therapy market share is expected to increase by USD 434.26 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.38%.

Artificial Eye Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.16%

Market growth 2022-2026

$ 34140.17 th

Market structure

Fragmented

YoY growth (%)

7.5

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 57%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Advanced Artificial Eyes, Alcon Inc., Bionic Vision Technologies, Carl Zeiss AG, Erickson Laboratories, F.AD. Muller Sohne GmbH and Co. KG, Ferdinand A. Forster GmbH, Integrated Orbital Implants, International Prosthetic Eye Center, Marie Allen Ocularist Ltd., Midwest Eye Laboratories, Molteno Ophthalmic, Nano Retina, National Artificial Eye Services, Ocular Prosthetics Inc., PIXIUM VISION, Rocky Mountain Anaplastology Inc., Second Sight Medical Products Inc., Artificial Eyes Pty Ltd., and NIDEK Co. Ltd

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio "Health Care" Research Reports

Table of Content:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact Us:

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 00:29
Cadence Education, LLC. ("Cadence Education"), one of the largest providers of early childhood education in North America, announced that its 2022 annual company-wide fundraising St. Jude Trike-A-Thon event has raised $330,145. This brings Cadence...

at 00:00
This webinar will enable attendees to understand and comply with the FDA's cell and gene therapy...

30 nov 2022
IVERIC bio, Inc. (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions. In addition,...

30 nov 2022
CNS Pharmaceuticals, Inc. ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of a public...

30 nov 2022
Aura Biosciences, Inc. ("Aura") , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of...

30 nov 2022
Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") , a publicly traded special purpose acquisition company ("SPAC") formed for the...



News published on 25 september 2022 at 21:15 and distributed by: